Premium
Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy ( OPAT ) setting?
Author(s) -
Rae Nikolas,
Kenny Claire,
Muldoon Eavan G.
Publication year - 2019
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12874
Subject(s) - medicine , antimicrobial , antifungal , intravenous therapy , intensive care medicine , dermatology , microbiology and biotechnology , biology
Summary Outpatient parenteral antimicrobial therapy ( OPAT ) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT .